Acta Biomaterialia-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2020-02-21 hewty

审稿速度:3.0
经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！

155 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2020-02-13 上天擒佛祖

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审稿越来越严苛，没四个月不可能搞得定

110 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2019-07-08 ms9821035889741998

2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见

74 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2019-02-22 ms3309476956082021

7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。

90 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2018-12-06 ms8838453850558450

6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献

60 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2018-07-18 ms6459520362745523

挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、

58 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2018-05-22 ms887994580797846

效率很高，主编认为不适合该期刊，3天拒稿

58 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2018-02-03 12136a34m19(暂无昵称)

最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表:
July 7评审意见终于出来了:大修.

zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修.

307 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2017-12-22 megatr0n

审稿速度:2.0
经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗

325 0

[GetPortalCommentsPageByObjectIdResponse(id=585156, encodeId=caff58515652, content=审稿速度:3.0 经验分享：前后4个月接收，有5个reviewer共计20多条意见。语法编辑给改的。编辑还为delay in the process of decision道歉。严谨、友好、有效率的期刊！明天应该破7！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Fri Feb 21 23:45:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584695, encodeId=c6f458469529, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿越来越严苛，没四个月不可能搞得定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/14/218f529a0e2c92b8bd51714f754a0998.jpg, createdBy=48832083483, createdName=上天擒佛祖, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852456, encodeId=d11b852456f7, content=2018年12月投稿，一审一个月，一个月后修回，二审一个月左右，一个月后修回，三审两周，两周后修回，两周后接收，整体比较慢，但审稿人认真负责，提出了较多重要修改意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Mon Jul 08 10:45:45 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849826, encodeId=9a17849826ee, content=7月底投稿，9月初一审大修1个月，编辑人很好，研究方向生物医学工程，编辑分别找了化学，医学临床和生理学三个审稿人。每个审稿人提的问题都很多，很专业，给编辑写信申请延期，同意延期14天。9月底修回，二审1个月，小修，1个月后修回，三修小修，投出14天后接受。7月份投稿，1月中旬接收，历时半年，感觉有些慢。投稿心得：一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Fri Feb 22 16:10:34 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848502, encodeId=a1bb8485021e, content=6月8号投稿，8月初一审大修1个月，3个审稿人，每个审稿人提的问题都很尖锐，很专业，其中一个审稿人要求补个动物实验，给编辑写信申请延期，编辑人很好，同意。10月中旬修回，二审1个月，小修，4天修后直接接受。一定要好好回答审稿人问题，能补的实验尽量补，不能补的就合理回复或引用文献 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Dec 06 04:52:04 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845446, encodeId=f87084544650, content=挺不错的期刊，一般2个月给一审结果，3个审稿，认真负责，biomaterials中不了了，推荐首选试一试这个。在最近这么多新的生物类杂志出来的情况下，很乐观看涨、 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Wed Jul 18 20:45:54 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843319, encodeId=1455843319aa, content=效率很高，主编认为不适合该期刊，3天拒稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Tue May 22 17:13:33 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552322, encodeId=8d195523225e, content=最后接受了吗?zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., beContent=zhengyuanyi 2015-07-12 23:36:00 发表: July 7评审意见终于出来了:大修., objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19752236974, createdName=12136a34m19(暂无昵称), createdTime=Sat Feb 03 00:00:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550233, encodeId=2f20550233b2, content=审稿速度:2.0 经验分享：一审一个半月，有三个审稿人给出意见，然而奇怪的是reviewer1,2,4.，不知道为什么没有审稿人3，其中1和2的意见都是比较积极的，4号审稿人比较奇葩，明显带有歧视的意思，关于文章实验设计方面基本没有提出什么建设性的意见，都是在挑语言和书写的问题，甚至连参考文献里面亚洲地区的研究所占比例过高都表达了不满，最后来了一句创新性不强，不适合发表在acta biom上，最终编辑采纳了4号审稿人的意见，拒稿，呵呵。亚洲人吃你家米了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Fri Dec 22 12:52:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548477, encodeId=6b505484e756, content=2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ac698829, createdName=megatr0n, createdTime=Mon Oct 23 10:35:00 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

2017-10-23 megatr0n

2016 IF 6.319 从杂志主页查询到的，不知道审稿周期如何

335 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务